NTRK2 and central nervous system cancer: Replicating this experiment using an orthogonal approach, we knocked down NTRK2 expression using short hairpin RNA (shRNA) rather than CRISPR-mediated deletion, demonstrating a similar reduction in synaptic puncta in TrkB-deficient glioma cells (Extended Data Fig. 10b–d).